VAALCO Energy, Inc. Declares Third Quarter 2025 Dividend GlobeNewswire August 07, 2025 HOUSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) — Vaalco Energy, Inc. (NYSE: EGY; LSE: EGY) (“Vaalco” or the “Company”) today announced that it declared its quarterly cash dividend of $0.0625 per share of common stock for the third quarter of 2025 ($0.25 annualized), which […]
Synaptics Reports Fourth Quarter and Full Year Fiscal 2025 Results GlobeNewswire August 07, 2025 Fiscal 2025 revenue grew 12.0%, fueled by 53% growth in Core IoT product sales Synaptics' Board of Directors approved a new share repurchase program of up to $150 million Fiscal 2025 Financial Highlights Revenue of $1.074 billion increased 12% year-over-year Core
Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares GlobeNewswire August 07, 2025 Offering included participation from leading institutional investors, including Nantahala Capital, ADAR1 Capital Management, Second Line Capital, 683 Capital, and SilverArc Capital Proceeds expected to extend cash runway through key upcoming 3-and
Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC GlobeNewswire August 07, 2025 6-month follow-up for NDV-01 showed a 91% overall response rate at any time in non-muscle invasive bladder cancer, with good overall safety Enrollment in the Phase 2 study for NDV-01 continues, with
Century Aluminum Company Reports Second Quarter 2025 Results GlobeNewswire August 07, 2025 CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Century Aluminum Company (NASDAQ: CENX) today announced its second quarter 2025 results. Second Quarter 2025 Financial Results $MM (except shipments and per share data) Q2 2025 Q1 2025 Aluminum shipments (tonnes) 175,741 168,672 Net sales $
Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 CANTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial
AvePoint Announces Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 Total quarterly revenue surpassed $100 million for the first timeSecond quarter SaaS revenue of $77.3 million, representing 44% year-over-year growth, 40% on a constant currency basisSecond quarter Total revenue of $102.0 million, representing 31% year-over-year growth, 27% on a constant currency basisTotal ARR of
(NasdaqGM:AVDL), DUBLIN, Aug. 07, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel's Board of Directors approved the grant of non-statutory options to eight (8) new employees to purchase 60,400 ordinary shares under Avadel's 2021 Inducement Plan. The
Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth GlobeNewswire August 07, 2025 CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation, an advanced energy technology company and manufacturer of Renuvion(R) and the newly launched AYON Body Contouring System(TM), today announced the strategic appointments of two
(NASDAQ:CARG), Sustained strong momentum in the Marketplace business, with revenue up 14% YoY Q2'25 Net Income of $22.3 million; Non-GAAP Adjusted EBITDA of $77.3 million, up 39% YoY Board approves additional $150 million share repurchase, increasing 2025 authorization to $350 million and extending it through July 2026 BOSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) — CarGurus,